Public Health and Preventive Medicine
Articles Information
Public Health and Preventive Medicine, Vol.1, No.3, Aug. 2015, Pub. Date: Jun. 30, 2015
Co-Morbidity of Multiple Chemical Sensitivity (MCS) and Chronic Fatigue Syndrome (CFS): Which Comes First
Pages: 108-111 Views: 4976 Downloads: 1263
Authors
[01] Harold I. Zeliger, Zeliger Research and Consulting, Department of Toxicology, Cape Elizabeth, Maine, USA.
[02] Bernard Possidente, Department of Biology, Skidmore College, Saratoga Springs, New York, USA.
[03] Abby G. Drake, Department of Biology, Skidmore College, Saratoga Springs, New York, USA.
Abstract
The co-morbidity of multiple chemical sensitivity (MCS) and chronic fatigue syndrome (CFS) has previously been reported. The present study was aimed to ascertain if either of the two conditions preceded the other in individuals affected with both conditions. An online survey of patients suffering from both MCS and CFS was undertaken. Those suffering from both of these conditions were asked which condition preceded the other. The results showed that 58% of the respondents were co-morbid with both conditions. Approximately half of the respondents reported the onset of MCS first (54%) while approximately half (46%) reported the prior onset of CFS. It is concluded that there is no significant bias with respect to either condition preceding the other in cases of co-morbidity. A mechanism for the onset of these diseases and suggestions for lowering their incidences are made.
Keywords
Multiple Chemical Sensitivity, Chronic Fatigue Syndrome, Environmental Disease, Disease Co-Morbidity
References
[01] Caress SM, Steinemann AC. Asthma and chemical hypersensitivity: prevalence, etiology, and age of onset. Toxicol Ind Health 2009; 25:71-78.
[02] Brown MM, Jason LA. Functioning in individuals with chronic fatigue syndrome: increased impairment with co-concurring multiple chemical sensitivity and fibromyalgia. Dyn Med 2007, 6: 6.
[03] De Luca C, Raskovic D, Pacifico V, Thai JC, Korkina L. The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances. Int J Environ Res Piblic Health 2011; 8(7):2770-97.
[04] Kreutzer R, Neutra RR, Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based study. Am J Epidemiol1999; 150(1):1-12.
[05] Centers for Disease Control. The 1994 case definition: CFS. http://www.cdc.gov/cfs/case-definitionII994.html (accessed December 9,2013).
[06] Johnson S, Brenu EW, Staines D, Marshall-Gradisnik S. The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis. Clinical Epidemiol 20 I 3; 20 I 3(5): 105- I 10.
[07] Underhill R. Chronic fatigue syndrome in children and adolescents. New Jersey Chronic Fatigue Syndrome Assoc. http://njcfsa.orgiFACTPEDLhtml (accessed December 12, 2013.
[08] Ciccione DS, Natelson BH. Comorbid illness in women withchronic fatigue syndrome: A test of the single syndromehypothesis. Psychosom Med 2003; 65:268-75.
[09] Jason LA, Taylor RR, Kennedy CL. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in community-based sample of persons with chronic fatigue-like symptoms. Psychosom Med 2000; 62(5):655-63.
[10] Buchwald D, Garrity D.Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Int Med 1994; 154(18):2049-53.
[11] Mcnemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychmetrika 1947; 12(2):153-57.
[12] Zeliger HI. Co-morbidities of environmental diseases: A common cause. Interdiscip Toxicol2014; 7(3): 10 1-106.
[13] Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. Hypertension 1995; 26:869-79.
[14] Zeliger HI. Toxic effects of chemical mixtures. Arch Environ Health 2003; 58 (1): 23-29.
[15] Zeliger HI. Human toxicology of chemical mixtures, 2nd ed., Elsevier, London.
[16] Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, Jacobs DR Jr. A strong dose-response relationship between serum concentrations of persistent organic pollutants and diabetes. Diabetes Care 2006; 29(7): 1638-44.
[17] Law MR, Morris J, Watt HC, Wald NJ. The dose-response relationship between cigarette consumption, biochemical markers and risk oflung cancer. Br J Cancer 1997; 75(11):1690-93.
[18] Zeliger HI, Pan Y, Rea WJ. Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis. 1nterdiscip Toxicol2012; 5(3): 123-26.
[19] Aaron LA Herrel R, Ashton S, Belcourt M, Schmaling K, Goldberg J, Buchwald D. Comorbid clinical conditions in chronic fatigue. J Gen Intern Med 2001; 16: 24- 31.
600 ATLANTIC AVE, BOSTON,
MA 02210, USA
+001-6179630233
AIS is an academia-oriented and non-commercial institute aiming at providing users with a way to quickly and easily get the academic and scientific information.
Copyright © 2014 - American Institute of Science except certain content provided by third parties.